Page last updated: 2024-10-28

glipizide and Asymmetric Diabetic Proximal Motor Neuropathy

glipizide has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Research Excerpts

ExcerptRelevanceReference
"Diet or tablet-treated patients with Type 2 diabetes (n = 256; age 40-75 years, body mass index (BMI) 20-35 kg/m2, HbA1c 4."2.70Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study. ( Dejgaard, A; Kilhovd, B; Lager, I; Madsbad, S; Mustajoki, P, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Madsbad, S1
Kilhovd, B1
Lager, I1
Mustajoki, P1
Dejgaard, A1

Trials

1 trial available for glipizide and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:5

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies

2001